Trihexyphen

Quick links to important sections

Trihexyphen

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trihexyphen

What is Trihexyphen? Defining the Medicinal Entity

Property Description
Active ingredient Trihexyphenidyl Hydrochloride (Benzhexol)
Form Tablet, Elixir
Pharmacological class Centrally Acting Anticholinergic Agent
Common use Management of involuntary muscle movement
Origin Synthetic

The medicine known generally as Trihexyphen is a designation for the compound whose active ingredient is Trihexyphenidyl Hydrochloride, also known as Benzhexol. This compound is a synthetic substance manufactured through chemical synthesis and is supplied as a single-ingredient product. Trihexyphenidyl is prepared for oral administration in the systemic forms of either a tablet or an elixir. The formulation includes the active compound alongside standard pharmaceutical excipients. Its duration of action, typically spanning six to twelve hours, is a distinctive feature of its pharmacokinetic profile.


What Type of Medicine is Trihexyphenidyl?

Trihexyphenidyl is classified within pharmacology as a centrally acting Anticholinergic Agent and an Antispasmodic. This classification is based on the drug's affinity for muscarinic receptors and signifies the drug's ability to influence the balance of nerve signals within the central nervous system (CNS).

The medicine works through a central cholinergic receptor blockade, which means it specifically modulates the influence of the neurotransmitter acetylcholine in the brain. Unlike drugs that primarily target the dopaminergic system, Trihexyphenidyl differentiates itself by targeting the cholinergic system to achieve signal regulation.


General Purpose and Benefit of this Anticholinergic Agent

The general purpose of Trihexyphenidyl is to help manage the symptoms of certain involuntary muscle movement disorders. Its mechanism involves crossing the blood-brain barrier to act centrally, providing a way to alleviate excessive muscle rigidity and reduce the severity of tremors and muscle stiffness. The typical use scenario for Trihexyphenidyl involves its administration to patients with motor issues. Its primary benefit is providing greater control over involuntary contractions, thus improving a patient's overall motor function and easing the difficulty associated with movements.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Trihexyphen?

Possible side effects and safety information

The safety profile for Trihexyphenidyl Hydrochloride (Trihexyphen) is documented by regulatory authorities, classifying adverse reactions primarily according to the drug's anticholinergic properties and its effects on the Central Nervous System (CNS).


Frequency and Common Reactions

Minor side effects are officially classified as common, potentially affecting 30% to 50% of patients. These frequent reactions include dry mouth, blurred vision, dizziness, and constipation. Official labeling notes that these minor effects often become less pronounced or may disappear with continued treatment.

System-Organ-Class Safety Groupings

The documented adverse reactions are categorized across several physiological systems:

  • Nervous System / Psychiatric: Dizziness, drowsiness, nervousness, restlessness, mental confusion, and disturbed behavior.
  • Gastrointestinal Disorders: Dry mouth, constipation, nausea, and vomiting.
  • Ophthalmic Disorders: Blurred vision and pupil dilation.
  • Urinary Disorders: Urinary hesitancy and urinary retention.

Serious Adverse Reactions and Safety Patterns

Regulatory sources document the risk of serious adverse reactions, which are less common but clinically significant. These include the potential precipitation of angle-closure glaucoma and severe gastrointestinal complications (such as paralytic ileus).

Population-Specific Considerations are mandated, with official labeling stating that older adults may exhibit increased sensitivity, leading to a higher risk of mental confusion and agitation. Patients with pre-existing conditions like prostatic hypertrophy or narrow-angle glaucoma are noted to require particular caution and close observation due to the inherent risks associated with anticholinergic agents. Additionally, the abrupt withdrawal of Trihexyphenidyl is officially associated with the risk of aggravated motor symptoms or the onset of Neuroleptic Malignant Syndrome (NMS).

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Trihexyphenidyl (Trihexyphen) is characterized by the official signs of central anticholinergic syndrome. Documented clinical manifestations primarily affect the central nervous system, including agitation, confusion, delirium, hallucinations, and seizures, potentially escalating to stupor or coma. Physical signs include mydriasis (dilated pupils), flushing, dry skin, tachycardia, and elevated body temperature (hyperpyrexia). Visceral effects such as urinary retention and paralytic ileus are also documented.


Severe Outcomes and Emergency Actions

Untreated overdose carries the risk of severe, life-threatening outcomes, which include circulatory failure, respiratory arrest, and cardiac arrest. Regulatory information notes that overdose may result in death, especially in children. Immediate medical attention must be sought if an overdose is suspected. Urgent contact with emergency services is required if the person has collapsed, has had a seizure, exhibits trouble breathing, or can't be awakened.


Management and Support

Treatment is defined as symptomatic and supportive therapy, as no specific antidote is known. This supportive approach includes measures to limit drug absorption, such as gastric lavage, and specific procedural steps to reverse complications, such as correcting hyperpyrexia. The use of phenothiazines is contraindicated due to the potential to intensify toxicity.

Therapeutic Uses of Trihexyphen

What Trihexyphen Treats: Main Uses and Benefits

The purpose of Trihexyphenidyl (Trihexyphen) is to provide targeted symptomatic relief and supportive motor control in specific neurological contexts. Its therapeutic value is centered on easing the burden of disruptive involuntary movement issues. In clinical practice, the medicine is used to help manage specific motor disorders.

Trihexyphenidyl is commonly used to help with conditions characterized by periods of heightened symptoms, including various forms of Parkinson's disease (Parkinsonism) and Extrapyramidal Disorders (EPD), particularly those arising as a side effect of other CNS medications. It may also be part of symptomatic management for conditions like dystonia and excessive salivation (sialorrhea).

“This supportive therapeutic approach helps maintain a sense of stability when symptoms are more noticeable, and may assist with general well-being during symptomatic phases.”

It is applied when symptomatic support is needed for symptoms related to physical discomfort, such as significant muscle rigidity, persistent tremors, and general slowness of movement. This application offers symptomatic relief that supports the patient's comfort during difficult episodes and helps ease the overall symptom burden.

Quick Fact: Supportive Relief for Muscle Rigidity and Tremors Trihexyphenidyl is commonly used to address symptoms of increased neurological or muscular activity associated with Parkinsonism and medication-induced motor issues, which may include support for better muscle control and flexibility.

Eligibility and Restrictions for Use

Who Can and Cannot Use Trihexyphenidyl?

The use of Trihexyphenidyl (Trihexyphen) is determined by official regulatory bodies, primarily based on the presence of specific health conditions and age. Eligibility is strictly defined by absolute prohibitions and conditional restrictions.

Contraindicated Populations (Must Not Use)

Trihexyphenidyl is absolutely contraindicated in patients with a known hypersensitivity to the active ingredient or any excipients. It must also not be used by patients with narrow angle glaucoma due to the risk of precipitating angle closure and elevated intraocular pressure.

Age and Condition-Based Restrictions

Population / Condition Eligibility Status Restriction Basis
Pediatric Patients (Under 18) Not Established Safety and effectiveness are not confirmed; use is generally not recommended by regulators.
Geriatric Patients (Over 60) Conditional Use Requires close observation and strict dosage regulation due to increased sensitivity to anticholinergic effects.
Pregnancy Conditional Use Use is not recommended unless clearly necessary due to insufficient human safety data (Pregnancy Category C).
Lactation Not Recommended The drug should not be used by breastfeeding mothers.
Obstructive Disease Use with Caution Patients with prostatic hypertrophy or obstructive diseases of the GI/genitourinary tracts require cautious monitoring.
Tardive Dyskinesia (TD) Not Recommended Not to be used unless the patient has concomitant Parkinson's disease, as it may exacerbate TD symptoms.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific drug-drug interactions that require close management or avoidance when using Trihexyphenidyl (Trihexyphen). These constraints are based on the drug's anticholinergic properties and its potential to interact with other substances.

Documented Interacting Medicines and Classes

The most significant interactions involve medicines that also possess anticholinergic properties. Co-administration with other anticholinergic agents, such as certain antihistamines, neuroleptics (antipsychotics), or tricyclic antidepressants, can lead to an enhanced potential for serious anticholinergic adverse reactions. Therefore, this combination may be restricted or require careful dosage monitoring.

Co-administration with Levodopa requires caution, as Trihexyphenidyl may enhance its effects but simultaneously increase the risk of movement abnormalities (dyskinesia). Conversely, the effects of drugs designed to stimulate gastrointestinal (GI) motility (e.g., metoclopramide) may be reduced when taken with this medicine.

Other Interaction Constraints

Specific products such as Potassium Chloride or Potassium Citrate may present an interaction risk. Co-administration of Trihexyphenidyl with these substances is generally not recommended and, if necessary, requires careful management of administration.

In certain populations, such as elderly patients, the risk of interactions and associated adverse effects may be higher, often necessitating the use of the lowest effective dose of Trihexyphenidyl.

Mechanism of Action

Trihexyphenidyl, a centrally-acting anticholinergic agent, modulates key neurological pathways by primarily engaging muscarinic receptors. This action results in the modulation of overactive or dysregulated processes, leading to altered physiological states.


Central Cholinergic Receptor Blockade

Trihexyphenidyl acts as an antagonist, binding selectively to muscarinic acetylcholine receptors (particularly the M1 subtype) within the central nervous system, notably in the striatum. This initiates a signaling sequence that suppresses the effects of the neurotransmitter acetylcholine, thereby altering the balance in systems where specific transmitters dominate motor control, and modulating excessive motor pathway output.


Peripheral Parasympathetic Inhibition and Smooth Muscle Effects

The drug also exerts effects in domains involving the peripheral parasympathetic nervous system, inhibiting efferent impulses in parasympathetically innervated structures. This engagement of mechanisms that modulate overactive processes extends to an effect on smooth musculature tone, which modifies early molecular steps that shape systemic physiological outcomes and results in the reduction of excessive mediator activity consequences.

Dosage and Administration Information

The administration of Trihexyphen (Trihexyphenidyl) is based on an oral route and a highly individualized dosing approach. The medicine is available as an oral solution (elixir) or as tablets in 2 mg and 5 mg strengths.

Administration Scope Guideline
Route of Administration Oral (Tablet or Elixir form).
Initial Dose 1 mg once daily on the first day.
Titration Increases by 2 mg increments at intervals of three to five days until the optimal level is achieved.
Maintenance Range Total daily dose typically ranges from 6 mg to 10 mg, with some patients requiring up to 12 mg to 15 mg.

The total daily intake is best tolerated when divided into multiple doses and taken at mealtimes. For total daily doses exceeding 10 mg, the intake should be divided into four parts, with three doses administered at mealtimes and the final dose taken at bedtime. The timing relative to food is adjustable: taking the dose before meals may help with excessive dry mouth, while taking it after meals is recommended if nausea or increased salivation occurs.

Population-Specific Rules

  • Older Adults (over 60): Requires a smaller initial dose and slower, more cautious titration due to increased sensitivity.
  • Concomitant Therapy: When used with levodopa, the usual dose of each medication, including Trihexyphenidyl (typically 3 mg to 6 mg daily in divided doses), may need to be reduced and carefully adjusted.

The entire course of therapy is defined by this gradual procedural sequence to establish the lowest effective dose, requiring ongoing patient observation.

Recent Clinical Evidence

Trihexyphen: Recent Clinical Evidence

The research overview below describes the general findings reported in key clinical trials and reviews concerning Trihexyphen. Trihexyphen was the subject of research focused on its potential role in Parkinson’s Disease (PD) and certain drug-induced movement disorders.

Initial Efficacy Trials

Early studies examined the drug’s use in adult patients and evaluated its potential role in acute symptoms associated with PD. The primary goal of this research was to observe the effects of anticholinergic activity on motor function.

  • Pivotal Study A: This Phase 3 trial reported that the drug group experienced a reduction in tremors and rigidity over the study period compared to the control group. The primary endpoint measured was the change in specific motor scores on established rating scales.

Research on Symptom Management

Other trials investigated the drug in relation to the severity and frequency of recurring involuntary movements associated with PD.

  • Study B: This randomized controlled trial (RCT) examined a large patient cohort. Findings indicated that the group receiving Trihexyphen showed greater change in movement disorder ratings compared to the placebo group.
  • Study C (Combination Research): Research has explored whether the drug's use in combination with standard levodopa therapy is associated with changes in overall quality of life. The study reported a greater change in quality of life metrics when compared to levodopa monotherapy alone.

Specific Population Research

Research has included studies in specific patient groups to assess its applicability across various demographics.

  • Geriatric Study D: A study evaluated Trihexyphen in older adult subjects. The study found the drug group experienced greater changes in certain motor control markers than the placebo group. Studies generally excluded individuals with severe cardiac or psychiatric comorbidities, and research involving these specific populations is limited.

Key Studies & References

  1. Trihexyphenidyl: MedlinePlus Drug Information (Authoritative overview of uses and safety)
  2. Trihexyphenidyl - LiverTox - Clinical and Research Information on Drug-Induced Liver Injury (General Drug Information and Background)
  3. TRIHEXYPHENIDYL HYDROCHLORIDE tablet - DailyMed (FDA-mandated Prescribing Information/Label)

Frequently Asked Questions (FAQ)

Common questions about Trihexyphen (FAQ)


Q: Does Trihexyphen help with muscle stiffness or only with shaking?

Trihexyphen is indicated for the management of symptoms associated with parkinsonism. Official product information states that its uses include helping to relieve symptoms such as stiffness, tremors (shaking), spasms, and generally improving poor muscle control.


Q: What happens if I miss a dose of Trihexyphen?

Official consumer guidance often advises taking the dose as soon as it is remembered. However, if it is almost time for your next scheduled dose, it is generally recommended to skip the missed dose and return to your regular schedule. It is generally advised not to take a double dose to compensate for a missed one.


Q: Can Trihexyphen make you feel sleepy or dizzy during the day?

Yes, regulatory documents list dizziness and drowsiness as common potential side effects of Trihexyphen. Because of these central nervous system (CNS) effects, caution is warranted when engaging in activities that require full mental alertness, such as operating a vehicle or machinery.


Q: Does Trihexyphen affect heart rate or blood pressure?

Trihexyphenidyl possesses anticholinergic properties, which may affect the cardiovascular system. Official safety information indicates that the drug may cause tachycardia (a rapid heart rate). Official guidance indicates that patients with cardiac issues or high blood pressure are often monitored closely.


Q: Can older adults safely take Trihexyphen, and are they more prone to side effects?

Older adults may be prescribed this medication, but they require a lower initial dose and careful adjustment. Official safety information states that older individuals may have an increased sensitivity and are at a higher risk for adverse reactions, particularly mental confusion and agitation. Such patients are often monitored closely.


Q: Are there known withdrawal symptoms if Trihexyphen is stopped suddenly?

Official warnings advise that stopping the drug suddenly should be avoided. Abrupt withdrawal may lead to an acute worsening of parkinsonism symptoms. In rare cases, it can also trigger a potentially serious condition referred to as a Neuroleptic Malignant Syndrome (NMS)-like symptom complex.


Q: Is it normal to experience difficulty urinating while taking Trihexyphen?

Difficulty in urination is a recognized side effect. Due to the drug's anticholinergic action, official labeling mentions the potential for urinary hesitancy and urinary retention. This is a side effect that should be discussed with a healthcare provider.


Q: Does Trihexyphen interact with alcohol?

Official precautions advise that the use of alcohol should be avoided while taking Trihexyphen. Alcohol is a central nervous system depressant, and its use may increase the sedative effects of the medication, potentially worsening drowsiness or dizziness.


Q: What does the research say about the long-term effectiveness of Trihexyphen?

The official product labeling indicates that the use of Trihexyphen may, in some cases, continue indefinitely when clinically indicated. For patients on long-term treatment, careful and constant medical observation is generally recommended to monitor for any reactions and ensure continued effectiveness.


Q: Is Trihexyphen the same as other Parkinson's medications I've heard of?

No, Trihexyphen is classified as a Centrally Acting Anticholinergic Agent, a specific drug class. It is typically indicated for use as an adjunct (supplement) to other common Parkinson's treatments, such as Levodopa, rather than being the same type of drug.


Q: Do the side effects of Trihexyphen go away over time?

According to official regulatory information, many of the minor side effects frequently reported, such as dry mouth or blurred vision, often become less pronounced or may disappear entirely with continued treatment. If side effects persist or are bothersome, consultation with a healthcare provider is appropriate.


Q: Is Trihexyphen a long-term treatment or is it usually temporary?

The official labeling notes that its use may, in some cases, continue indefinitely when clinically indicated. It is not necessarily a temporary medication, and its duration of use is determined by the individual condition and response, requiring careful monitoring over time.


Q: How is the dose of Trihexyphen usually determined?

The dosage is highly individualized for each patient. Treatment begins with a very low initial dose and is then gradually increased by the healthcare provider. This slow process continues until the lowest effective dose that provides the most benefit with the fewest side effects is established.


Q: What should I do if the side effects of Trihexyphen are bothering me?

If a severe or particularly troublesome reaction occurs, official guidance suggests that the medication may need to be temporarily discontinued for a few days. Following this, treatment may be resumed at a lower dosage. Any change to the dose or discontinuation should only occur under the direction of a healthcare professional.


Q: Is there any evidence about Trihexyphen use during pregnancy or breastfeeding?

Regulatory sources classify Trihexyphen as Pregnancy Category C, meaning its use during pregnancy is conditional. Use by breastfeeding mothers is not generally recommended due to insufficient safety data.


Q: Is Trihexyphen a controlled substance?

No, Trihexyphenidyl is not currently classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or the Food and Drug Administration (FDA).


Q: What are the signs of taking too much Trihexyphen?

Symptoms of an overdose or toxicity can include a combination of effects such as fever, dry skin, agitation, confusion, hallucinations, and a rapid heart rate (tachycardia). Immediate medical attention is required if an overdose is suspected.


Q: What are the less common, but serious, side effects of Trihexyphen I should know about?

Official labeling documents the risk of less common but serious reactions. These include the potential to precipitate angle-closure glaucoma and severe gastrointestinal problems such as paralytic ileus (a form of intestinal paralysis). Symptoms like vision changes or severe abdominal pain warrant immediate medical attention.


Q: How often is Trihexyphen usually taken throughout the day?

The total daily dosage is typically divided into multiple doses for better tolerance. Administration is usually recommended three times daily with meals, and for patients taking a higher total dose, an optional fourth dose may be added at bedtime.


Q: Can young adults or children use Trihexyphen for specific conditions?

The safety and effectiveness in pediatric patients (those under 18 years of age) have not been established by the regulators. Given this, the use of the medication in this population is generally not recommended.


Q: Is it safe to drive or operate machinery while taking Trihexyphen?

Official precautions warn that Trihexyphenidyl may impair mental and physical abilities. It is generally recommended not to drive or operate hazardous machinery until the drug's individual effects are understood.


Q: Why does Trihexyphen sometimes cause confusion or hallucinations in some people?

The drug's primary action is a central cholinergic receptor blockade in the brain. This mechanism, which affects the balance of nerve signals, can lead to adverse effects on the nervous system. These psychiatric side effects, such as mental confusion and hallucinations, are more likely to occur in sensitive populations, particularly the elderly.


Q: Is Trihexyphen a cure for Parkinson's disease or just a symptom reliever?

Trihexyphen is indicated as an adjunct in the treatment and for the control of symptoms associated with parkinsonism. Official labeling confirms that it is used to help manage motor function and is considered a symptom reliever, not a cure for the underlying disease.


Q: Can Trihexyphen be crushed or chewed if someone has trouble swallowing pills?

The medication is manufactured in two forms: a tablet and an oral solution (elixir). If a person has difficulty swallowing pills, the liquid elixir form is available as an alternative, which eliminates the need to modify the tablet.


Q: Are there lifestyle changes that can improve the effectiveness of Trihexyphen?

Trihexyphen can impair the body's ability to regulate temperature by decreasing perspiration. Official warnings advise patients to avoid becoming overheated or dehydrated during exercise or in hot weather, as this may lead to fever or heat stroke.


Q: Can Trihexyphen affect your sleep patterns?

Yes, regulatory documents list nervous system side effects such as drowsiness and restlessness. These effects may potentially interfere with or alter your normal sleep patterns.


Q: How do I know if Trihexyphen is working for my condition?

The effectiveness is determined by the patient's individual requirements and response, which are monitored by the prescriber. Dosage is adjusted gradually until the desired relief of symptoms, such as reduced tremor or rigidity, is achieved and confirmed during regular medical visits.


Q: Does Trihexyphen have any impact on mood or anxiety?

Official adverse reaction reports list specific psychiatric effects, including nervousness, as well as other disturbances such as agitation and disturbed behavior. If noticeable mood changes occur, this information should be discussed with a healthcare provider.


Q: Is Trihexyphen a dopamine agonist?

No, Trihexyphenidyl is classified as a Centrally Acting Anticholinergic Agent. Its mechanism involves blocking the neurotransmitter acetylcholine, which is a different action than a dopamine agonist.


How should Trihexyphen be stored and disposed of?

How to Store and Dispose of Trihexyphen?

This medication must be stored according to specific regulatory requirements to maintain its stability and effectiveness.

  • Temperature and Container: Store Trihexyphen at Controlled Room Temperature, which is between 15 and 30 C (59 and 86 F). The medication must be kept in the original, tight, light-resistant container as defined by official pharmacopeia standards.
  • Handling: Protect the medication from freezing and excessive heat or moisture, and keep the container tightly closed. It must be stored out of the reach of children.
  • Disposal: Unused or expired Trihexyphen should be disposed of through a drug take-back program. If a local take-back option is unavailable, the medication is not on the regulatory 'flush list.' As an alternative, mix the drug with an undesirable substance (such as dirt or used coffee grounds), place the mixture into a sealed bag or container, and dispose of it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Trihexyphen found in:

A-Z Index: